LEXINGTON, Mass.--(BUSINESS WIRE)--
Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will
report its second quarter 2017 financial results on Tuesday, August 8,
2017, before the U.S. financial markets open. The Company will host a
conference call and webcast at 8:30 a.m. EDT to discuss second quarter
financial results and provide a business update. Individuals interested
in participating in the call should dial (855) 354-1855 (U.S. and
Canada) or (484) 365-2865 (International).
A live webcast may be accessed in the Investors
section of the Company's website at www.concertpharma.com.
Please log on to the Concert website approximately 15 minutes prior to
the scheduled webcast to ensure adequate time for any software downloads
that may be required. A replay of the webcast will be available on
Concert's website for three months.
Pharmaceuticals is a clinical stage biopharmaceutical company
focused on applying its DCE
Platform® (deuterated chemical entity platform) to create novel
medicines designed to address unmet patient needs. The Company's
approach starts with approved drugs in which deuterium substitution has
the potential to enhance clinical safety, tolerability or efficacy.
Concert has a broad
pipeline of innovative medicines targeting autoimmune and
inflammatory diseases and central nervous systems (CNS) disorders. For
more information please visit www.concertpharma.com.
Concert Pharmaceuticals Inc., the CoNCERT Pharmaceuticals Inc. logo and
DCE Platform are registered trademarks of Concert Pharmaceuticals, Inc.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170801005131/en/
Concert Pharmaceuticals, Inc.
Justine Koenigsberg, 781-674-5284
Source: Concert Pharmaceuticals, Inc.
News Provided by Acquire Media